ADRENAL GLANDS
SMS 3023
Dr. MohanaD r. alwan
Adrenal Glands
Suprarenal glandsSuprarenal glands
• Paired organ each weight
about 4 grams, pyramidal in
shape, located on the top of
the kidneys, one on each side
at the level of the T12
• It enclosed by fibro elastic
connective tissue capsule.
Adrenal glands
• Each gland is divided into tow parts:
– CortexCortex – outer part of gland
• Part of hypothalamus – pituitary – adrenal axis
• Secrete a variety of steroid hormones
– MedullaMedulla – inner part of gland, (20% of gland)
• Part of sympathetic nervous system
• Secrete catecholamines
– Both parts are structurally and functionally different
Adrenal glands
Adrenal cortex
• The large cortical cells are arranged into three
layers or zones :
– The zona glomerulosazona glomerulosa,
• The thin outermost layer
• Constitute about 15% of cortex
– The zona fasciculatazona fasciculata,
• The middle and largest portion
• Constitute about 75% of cortex.
– The zona reticulariszona reticularis,
• The innermost zone.
Histology of adrenal glands
Adrenal cortex
• Zona glomerulosa:Zona glomerulosa:
– Produce meniralocorticods
– Mainly aldosteronealdosterone (because it contain enzyme
aldosterone synthasealdosterone synthase))
Hormones that help control the balance of
minerals (Na+ and K+) and water in the blood
Adrenal cortex
• Aldosterone secretionAldosterone secretion
Adrenal cortex
• Zona fasciculata:Zona fasciculata:
– Produce glucocorticods
– Mainly cortisolcortisol andand corticosteronecorticosterone
– The human adrenal glands produce the equivalent
of 35–40 mg of cortisone acetate per day
– The secretion of these cells is controled by
hypothalamic-pituitary axis via ACTH
Hormone that play a major role in glucose
metabolism as well as in protein and lipid
metabolism
Adrenal cortex
• Zona reticularis:Zona reticularis:
– The innermost layer of the adrenal cortex, lying
deep to the zona faciculata and superficial to the
medulla.
– These cells produce androgensandrogens
Adrenal cortex
• Zona reticularis:Zona reticularis:
– The androgens produced includes
• Dehydroepiandrosterone (DHEA)
• Androstenedione
– Synthesized from cholesterolSynthesized from cholesterol
• DHEA is further converted to DHEA-sulfate via a
sulfotransferase
Adrenal cortex
• Zona reticularis:Zona reticularis:
– The androgens produced are released into the
blood stream and taken up in the testis and
ovaries to produce testosterone and the estrogens
respectively.
Regulation of
adrenal gland
secretion ACTH
Cortisol
Cortisol
Disorders of adrenal cortex
• Patient with adrenal disorders can presentPatient with adrenal disorders can present
with features related to:with features related to:
• HYPOFUNCTION OF THE GLANDHYPOFUNCTION OF THE GLAND
• HYPERFUNCTION OF THE GLANDHYPERFUNCTION OF THE GLAND
DISORDERS OF ADRENAL CORTEX
Adrenal hypofunction
• Outlines
– INTRODUCTION
– AETIOLOGY AND PATHOGENESIS
– CLINICAL FEATURES
– INVESTIGATIONS
– MANAGEMENTS
Adrenal Hypofunction
• Adrenal insufficiency leads to a reduction in the
output of adrenal hormones
– glucocorticoids and/or mineralocorticoids
• Two types of adrenal insufficiency
• Primary insufficiencyPrimary insufficiency
• inability of the adrenal glands to produce enough steroidinability of the adrenal glands to produce enough steroid
hormoneshormones
• Secondary insufficiencySecondary insufficiency
• inadequate pituitary or hypothalamic stimulation of the adrenalinadequate pituitary or hypothalamic stimulation of the adrenal
glandsglands
• CausesCauses
– Glucocorticoid treatmentGlucocorticoid treatment
– Autoimmune adrenalitisAutoimmune adrenalitis
– TuberculosisTuberculosis
– AdrenalectomyAdrenalectomy
– Secondary tumor depositsSecondary tumor deposits
– AmyloidosisAmyloidosis
– HaemochromatosisHaemochromatosis
– Histoplasmosis, tuberculosis, CMV, AIDSHistoplasmosis, tuberculosis, CMV, AIDS
– adrenal haemorrhageadrenal haemorrhage
Adrenal Hypofunction
Common
Adrenal Hypofunction
• CausesCauses
• Metabolic failure in hormone productionMetabolic failure in hormone production
• Congenital adrenal hyperplasia e.g. 21-hydroxylase
deficiency, 3-β-hydroxysteroid dehydrogenase
deficiency
• Enzyme inhibition e.g. ketoconazole
• Accelerated hepatic metabolism of cortisol e.g.
phenytoin, barbiturates, rifampicin
Adrenal Hypofunction
• Other causes
– ACTH blocking antibodies
– Mutation in ACTH receptor gene
– Adrenal hypoplasia congenita
– Familial adrenal insufficiency
Addison diseaseAddison disease
Autoimmune
Isolated or associated with other autoimmune
disease
Presents with tiredness, weight loss, skin
pigmentation
Aldestrone & cortisol low, high ACTH, high renin
Low sodium , high potasium
ACTH stimulation test
Adrenal antibodies
Treatment : cortisol + aldestrone
.
Addison’s disease: pathogenesis
• Progressive destruction of entire adrenal cortex ,
This is usually autoimmune based.
• Most likely the result of cytotoxic T lymphocytes,
although 50% of patients have circulating adrenal
antibodies.
Adrenal Hypofunction
Addison’s diseaseAddison’s disease
Primary hypoaldosteronismPrimary hypoaldosteronism
Addison’s disease: Clinical features
Common Less common
Tiredness, generalized
weakness, lethargy
Hypoglycemia
Anorexia, nausea, vomiting Depression
Hyponatremia
Hyperkalemia ,Hypercalcemia
Convulsions
Dizziness and postural
hypotension
Pigmentation
Loss of body hair (woman)
Addison’s disease: clinical features
• hyperpigmentationhyperpigmentation
Addison’s disease: clinical features
• HyperpigmentationHyperpigmentation
ADRENAL CRISIS
• Acute adrenal insufficiencyAcute adrenal insufficiency
• Medical emergency
• Acute in onset; can be fatal if not promptly
recognized and treated
• Clinical features :
• Severe hypovolaemia
• Dehydration
• Shock
• Hypoglycaemia
• possible mental confusion and loss of consciousness
ADRENAL CRISIS
• Causes :
• Precipitated by stress
• infection, trauma or surgery in patients with incipient
adrenal failure/treated with glucocorticoids if dosage is
not increase
• Adrenal haemorrhage
• due to cx of anticoagulant treatment
• Meningococcal septicaemia
INVESTIGATIONS (HORMONAL)
• Plasma cortisol concentration
• <50nmol/L at 0900H → effectively diagnostic
• >550nmol/L excludes the Dx
• ACTH stimulation test / Synacthen test
• Measurement of plasma ACTH
• Metyrapone test
• CRH stimulation test
• Plasma renin and aldosterone levels
PLASMA ACTH MEASUREMENT
• To differentiate between primary and
secondary adrenal failure
• Primary insufficiency - ACTH increased
• Secondary insufficiency - ACTH decreased
INVESTIGATIONS (HORMONAL)
• ACTH stimulation test / Synacthen test
SHORT TEST LONG TEST
 Take blood sample at 0900H
for measurement of cortisol
 Inject 250µg ACTH im or iv
 Take further blood sample
after 30 and 60 min for cortisol
measurement
 Day 1 : inject 1 mg depot ACTH
IM im
 Days 2 and 3 : repeat
 Day 4 : perform short ACTH
test
METYRAPONE TEST
• Measures the ability of the pituitary gland to
release ACTH in response to decreased blood
cortisol levels.
• Metyrapone inhibits cortisol production by
blocking the conversion of 11-deoxycortisol to
cortisol by 11-beta-hydroxylase
Addison’s disease
•
CRH STIMULATION TEST
• To differentiate between secondary adrenal
insufficiency dt pituitary or hypothalamic dis.
• Results :
• Pituitary disease – blunted or nil response
• Hypothalamic lesions – positive response
PLASMA RENIN AND ALDOSTERONE
• Give an indication of mineralocorticoid
activity.
• Adrenal insufficiency
– Low aldosterone level with high renin
Management
• Hormone replacementHormone replacement
• Life-long replacement therapy
• Hydrocortisone and 9α-fludrocortisone
• Secondary adrenocortical insufficiency
• Hormone replacement
• may also require more definitive treatment e.g.
surgical removal of a pituitary tumour.
Management
• Adrenal crisis :
• Adequate resuscitation e.g. IV fluids, IV glucose.
• IV hydrocortisone 100mg which should be
continued four times daily afterwards until the
patient can take oral medication.
Disorders of adrenal cortexDisorders of adrenal cortex
Adrenal Dysfunction
Increase function
• Cushing syndrome
High Cortisol
• Hyperaldosteronism
High aldestrone
• Pheochromocytoma
High catecholamine
.
Hyperaldosteronism
• A medical condition where too much
aldosterone is produced by the adrenal glands,
which can lead to sodium retention and
potassium loss.
• Types:
– Primary hyperaldosteronism
– Secondary hyperaldosteronism
Primary hyperaldosteronismPrimary hyperaldosteronism
(hyporeninemic hyperaldosteronism)(hyporeninemic hyperaldosteronism)
Conn’s syndromeConn’s syndrome
Primary aldosteronismPrimary aldosteronism
CONN’S SYNDROME
• Characterized by autonomous excessive
production of aldosterone by adrenal glands
• Presents with HPT, hypokalaemic alkalosis
and renal K+ wasting
Conn’s Syndrome
• Causes:
– Adrenal adenoma
– Bilateral hypertrophy of zona glomerulosa cells
– Adrenal carcinoma
• Rare cause
Secondary aldosteronism
• Is increased adrenal production ofIs increased adrenal production of
aldosterone in response to non-pituitary,aldosterone in response to non-pituitary,
extra-adrenal stimuliextra-adrenal stimuli
• Increase renin secretion
– (hyperreninemic hyperaldosteronism)
• Commoner than primary aldosteronism
Secondary aldosteronism
• Common
– CCF
– Liver cirrhosis with ascites
– Nephrotic Syndrome
• Less common
– Renal artery stenosis
– Sodium – losing nephritis
– Renin-secreting tumours
Conn’s syndrome
• Clinical features:
– HypertensionHypertension : aldosterone induced Na retention with
increase in ECF volume
– Muscle weaknessMuscle weakness: Due to decrease K+
– Muscle paralysis:Muscle paralysis: severe hypokalaemia
– Latent tetanytetany and paraesthesiaeparaesthesiae
– PolydipsiaPolydipsia, polyuriapolyuria and nocturianocturia: due to hypokalaemic
nephropathy
INVESTIGATION
• Electrolyte & blood gasses:Electrolyte & blood gasses:
– Hypernatraemia
– Hypokalaemica
– Alkalosis
– Urinary potassium loss, level > 30 mmol daily during
hypokalaemia
INVESTIGATION
• Plasma aldosterone : renin activity ratioPlasma aldosterone : renin activity ratio
– Sensitive screening test
– No need to standardize posture
Ratio Interpretation Action
<800 Diagnosis excluded Seek other cause
>1000,<2000 Diagnosis possible Confirmatory test
>2000 Diagnosis very likely Establish cause
Diagnosis
• Perform saline infusion test (sodium loading)Perform saline infusion test (sodium loading)
– Method :
infusion of 1.25L of 0.9%saline over 2 hrs
– Result:
plasma aldosterone remains >240 pmol/l confirm
Conn’s syndrome
Establish cause
• Plasma Aldosterone level
• Method:
– Morning blood sample (pt stayed recumbent
since waking)
– Second sample after 4 hrs stayed ambulant
**Standing renal blood flow  stim renin sec
 aldosterone level
• Imaging techniques
– CT scan
– MRI
– Can differentiate adenoma from hyperplasia
Establish cause
Treatment
• Tumour
– Remove surgically
• Bilateral adrenal hyperplasia
– Spironolactone
Disorders of adrenal cortexDisorders of adrenal cortex
CUSHING’S SYNDROME
• Definition
• Clinical features
• Investigations
– Screening for Cushing’s syndrome
– Elucidation of the cause of Cushing’s syndrome
• Management
CUSHING’S SYNDROME
Adrenal cortex hyperfunction
• Any condition resulting from overproduction of
primarily glucocorticoid (cortisol)
• Mineralocorticoid and androgen may also be
excessive
Pseudo-Cushing’s syndrome
• Appear cushingoid and have some biochemical
abnormalities of true Cushing’s disease
• Causes
– Severe depression
– Alcoholism
– Obesity
– Polycystic ovarian syndrome
Etiology
• Excessive cortisol (ACTH dependent)~~75%
– Pituitary disease
• Adenoma (90%)
• Hyperplasia (10 %)
– Ectopic ACTH syndrome
• Malignancy - ( bronchus, thymus, pancreas, ovary )
– Ectopic CRH syndrome
– Exogenous ACTH administration
ACTH dependent causes
ACTH dependent causes
*Hypersecretion of ACTH and Cortisol is greater in ectopic ACTH syndrome
than Cushing Disease
Etiology
• Excessive cortisol (ACTH independent) ~25%~25%
– Adrenal tumour
• Adenoma
• carcinoma
– Nodular hyperplasia
– Exogenous glucocorticoid administration
ACTH independent causes
Etiology
• Excess cortisol binding globulinExcess cortisol binding globulin
– Estrogen therapy : Osteoporosis, OCP
– Pregnancy
Clinical features
• Truncal obesity with deposition of adipose tissue in
characteristic site (moon face, buffalo hump)– exact
mechanism unknown
• Thinning of skin – catabolic response
• Purple striae – catabolic response
• Excessive bruising – catabolic response
Cont..
• Hirsutism ( esp adrenal carcinoma ) - ↑ adrenal
androgen
• Menstrual irregularities - ↑ adrenal androgen
• Skin pigmentation ( ACTH ↑ ) – melanocyte
stimulating activity
Cont..
• Hypertension – mineralocorticoid effect → sodium
retention
– Potassium wasting → hypokalamic alkalosis
• Glucose intolerance - ↑ hepatic gluconeogenesis and
insulin resistance
• Muscle weakness and wasting – catabolic response
in peripheral supportive tissue
Cont..
• Back pain ( osteoporosis and vertebral collapse) –
inhibit bone formation
• Psychiatric disturbances – euphoria, mania,
depression
Laboratory investigations
 There are two diagnostic steps in the investigation
of patient suspected of having Cushing's syndrome
 Screening test
for identification of Cushing's syndrome.
the demonstration of high plasma cortisol level
 Identification of cause
1. Demonstration of increased cortisol
 Assessment of circadian rhythm in cortisol secretion
 24-Hour urinary free cortisol excretion
 Overnight / low dose dexamethasone suppression
test
Laboratory investigations
1. Assessment of circadian rhythm in cortisol
secretion.
 Measure 8 am and 11 pm serum cortisol
level
 Normal : Serum value @ midnight is 50% less than value
@ 8 am
 Cushing’s syndrome : rhythum is loss
 Pseudo-Cushing : normal circadian.
Laboratory investigations
2. Measuring 24-hour urinary free cortisol
Level (umol/ 24 h )Level (umol/ 24 h ) InterpretationInterpretation
< 300< 300 NormalNormal
300 - 700300 - 700 Severe depressionSevere depression
StressStress
> 700> 700 Diagnostic ofDiagnostic of
Cushing's syndromeCushing's syndrome
Laboratory investigations
3. Low dose Dexamethasone suppression test :
 0.5 mg Dexametason (oral) given 6 hourly for 2 days
 blood for plasma cortisol collected 6 hour after last dose
 urine for UFC is collected before & on the 2nd day of
Dexa
 Result:
 UFC suppress by 50% ( < 70nmol/24h) normal
 plasma cortisol suppress < 140 nmol/L pseudo-
Cushing
 no suppression of UFC & Pl. cortisol Cushing's synd
Elucidation of the cause
• High dose Dexamethasone suppression test
• Normal individuals suppress plasma cortisol to
< 50 nmol/L.
• Patients with Cushing's syndrome fail to show
complete suppression of plasma cortisol levels.
This test is highly sensitive (> 97%).
2. Elucidation of the cause
• Plasma ACTH
– Normal < 50 ng/L
– Low – adrenal causes
– Elevated
• Slight – pituitary dependent Cushing’s
• Gross – ectopic secretion of ACTH
Elucidation of the cause
• CRH Test
– Differentiate ectopic ACTH secretion and
Cushing’s disease.
– Cushing’s disease – plasma ACTH increases 50%
over baseline and cortisol increase by 20%
– Ectopic ACTH or adrenal tumour – no response
Elucidation of the cause
• Imaging
– CT scan of adrenal gland: TRO adrenal tumor
– MRI of pituitary gland: majority microadenoma
( < 10mm). MRI reveal lesion in 50 - 60% of cases
– CT scan/MRI of thorax & abdomen: ectopic ACTH
producing tumor
Treatment
• Depend of Cushing's syndrome depends on the
etiology:
– Adrenal adenoma
– Adrenal Carcinoma – resection
– Cushing’s disease - transphenoidal hyposectomy
– Drug ( block cortisol synthesis ) - metyrapone
adrenal glands disorder

adrenal glands disorder

  • 1.
  • 2.
    Adrenal Glands Suprarenal glandsSuprarenalglands • Paired organ each weight about 4 grams, pyramidal in shape, located on the top of the kidneys, one on each side at the level of the T12 • It enclosed by fibro elastic connective tissue capsule.
  • 3.
    Adrenal glands • Eachgland is divided into tow parts: – CortexCortex – outer part of gland • Part of hypothalamus – pituitary – adrenal axis • Secrete a variety of steroid hormones – MedullaMedulla – inner part of gland, (20% of gland) • Part of sympathetic nervous system • Secrete catecholamines – Both parts are structurally and functionally different
  • 4.
  • 5.
    Adrenal cortex • Thelarge cortical cells are arranged into three layers or zones : – The zona glomerulosazona glomerulosa, • The thin outermost layer • Constitute about 15% of cortex – The zona fasciculatazona fasciculata, • The middle and largest portion • Constitute about 75% of cortex. – The zona reticulariszona reticularis, • The innermost zone.
  • 6.
  • 7.
    Adrenal cortex • Zonaglomerulosa:Zona glomerulosa: – Produce meniralocorticods – Mainly aldosteronealdosterone (because it contain enzyme aldosterone synthasealdosterone synthase)) Hormones that help control the balance of minerals (Na+ and K+) and water in the blood
  • 8.
    Adrenal cortex • AldosteronesecretionAldosterone secretion
  • 9.
    Adrenal cortex • Zonafasciculata:Zona fasciculata: – Produce glucocorticods – Mainly cortisolcortisol andand corticosteronecorticosterone – The human adrenal glands produce the equivalent of 35–40 mg of cortisone acetate per day – The secretion of these cells is controled by hypothalamic-pituitary axis via ACTH Hormone that play a major role in glucose metabolism as well as in protein and lipid metabolism
  • 10.
    Adrenal cortex • Zonareticularis:Zona reticularis: – The innermost layer of the adrenal cortex, lying deep to the zona faciculata and superficial to the medulla. – These cells produce androgensandrogens
  • 11.
    Adrenal cortex • Zonareticularis:Zona reticularis: – The androgens produced includes • Dehydroepiandrosterone (DHEA) • Androstenedione – Synthesized from cholesterolSynthesized from cholesterol • DHEA is further converted to DHEA-sulfate via a sulfotransferase
  • 12.
    Adrenal cortex • Zonareticularis:Zona reticularis: – The androgens produced are released into the blood stream and taken up in the testis and ovaries to produce testosterone and the estrogens respectively.
  • 13.
  • 14.
    Disorders of adrenalcortex • Patient with adrenal disorders can presentPatient with adrenal disorders can present with features related to:with features related to: • HYPOFUNCTION OF THE GLANDHYPOFUNCTION OF THE GLAND • HYPERFUNCTION OF THE GLANDHYPERFUNCTION OF THE GLAND
  • 15.
  • 16.
    Adrenal hypofunction • Outlines –INTRODUCTION – AETIOLOGY AND PATHOGENESIS – CLINICAL FEATURES – INVESTIGATIONS – MANAGEMENTS
  • 17.
    Adrenal Hypofunction • Adrenalinsufficiency leads to a reduction in the output of adrenal hormones – glucocorticoids and/or mineralocorticoids • Two types of adrenal insufficiency • Primary insufficiencyPrimary insufficiency • inability of the adrenal glands to produce enough steroidinability of the adrenal glands to produce enough steroid hormoneshormones • Secondary insufficiencySecondary insufficiency • inadequate pituitary or hypothalamic stimulation of the adrenalinadequate pituitary or hypothalamic stimulation of the adrenal glandsglands
  • 18.
    • CausesCauses – GlucocorticoidtreatmentGlucocorticoid treatment – Autoimmune adrenalitisAutoimmune adrenalitis – TuberculosisTuberculosis – AdrenalectomyAdrenalectomy – Secondary tumor depositsSecondary tumor deposits – AmyloidosisAmyloidosis – HaemochromatosisHaemochromatosis – Histoplasmosis, tuberculosis, CMV, AIDSHistoplasmosis, tuberculosis, CMV, AIDS – adrenal haemorrhageadrenal haemorrhage Adrenal Hypofunction Common
  • 19.
    Adrenal Hypofunction • CausesCauses •Metabolic failure in hormone productionMetabolic failure in hormone production • Congenital adrenal hyperplasia e.g. 21-hydroxylase deficiency, 3-β-hydroxysteroid dehydrogenase deficiency • Enzyme inhibition e.g. ketoconazole • Accelerated hepatic metabolism of cortisol e.g. phenytoin, barbiturates, rifampicin
  • 20.
    Adrenal Hypofunction • Othercauses – ACTH blocking antibodies – Mutation in ACTH receptor gene – Adrenal hypoplasia congenita – Familial adrenal insufficiency
  • 21.
    Addison diseaseAddison disease Autoimmune Isolatedor associated with other autoimmune disease Presents with tiredness, weight loss, skin pigmentation Aldestrone & cortisol low, high ACTH, high renin Low sodium , high potasium ACTH stimulation test Adrenal antibodies Treatment : cortisol + aldestrone .
  • 22.
    Addison’s disease: pathogenesis •Progressive destruction of entire adrenal cortex , This is usually autoimmune based. • Most likely the result of cytotoxic T lymphocytes, although 50% of patients have circulating adrenal antibodies. Adrenal Hypofunction Addison’s diseaseAddison’s disease Primary hypoaldosteronismPrimary hypoaldosteronism
  • 23.
    Addison’s disease: Clinicalfeatures Common Less common Tiredness, generalized weakness, lethargy Hypoglycemia Anorexia, nausea, vomiting Depression Hyponatremia Hyperkalemia ,Hypercalcemia Convulsions Dizziness and postural hypotension Pigmentation Loss of body hair (woman)
  • 24.
    Addison’s disease: clinicalfeatures • hyperpigmentationhyperpigmentation
  • 25.
    Addison’s disease: clinicalfeatures • HyperpigmentationHyperpigmentation
  • 26.
    ADRENAL CRISIS • Acuteadrenal insufficiencyAcute adrenal insufficiency • Medical emergency • Acute in onset; can be fatal if not promptly recognized and treated • Clinical features : • Severe hypovolaemia • Dehydration • Shock • Hypoglycaemia • possible mental confusion and loss of consciousness
  • 27.
    ADRENAL CRISIS • Causes: • Precipitated by stress • infection, trauma or surgery in patients with incipient adrenal failure/treated with glucocorticoids if dosage is not increase • Adrenal haemorrhage • due to cx of anticoagulant treatment • Meningococcal septicaemia
  • 28.
    INVESTIGATIONS (HORMONAL) • Plasmacortisol concentration • <50nmol/L at 0900H → effectively diagnostic • >550nmol/L excludes the Dx • ACTH stimulation test / Synacthen test • Measurement of plasma ACTH • Metyrapone test • CRH stimulation test • Plasma renin and aldosterone levels
  • 29.
    PLASMA ACTH MEASUREMENT •To differentiate between primary and secondary adrenal failure • Primary insufficiency - ACTH increased • Secondary insufficiency - ACTH decreased
  • 30.
    INVESTIGATIONS (HORMONAL) • ACTHstimulation test / Synacthen test SHORT TEST LONG TEST  Take blood sample at 0900H for measurement of cortisol  Inject 250µg ACTH im or iv  Take further blood sample after 30 and 60 min for cortisol measurement  Day 1 : inject 1 mg depot ACTH IM im  Days 2 and 3 : repeat  Day 4 : perform short ACTH test
  • 31.
    METYRAPONE TEST • Measuresthe ability of the pituitary gland to release ACTH in response to decreased blood cortisol levels. • Metyrapone inhibits cortisol production by blocking the conversion of 11-deoxycortisol to cortisol by 11-beta-hydroxylase
  • 32.
  • 33.
    CRH STIMULATION TEST •To differentiate between secondary adrenal insufficiency dt pituitary or hypothalamic dis. • Results : • Pituitary disease – blunted or nil response • Hypothalamic lesions – positive response
  • 34.
    PLASMA RENIN ANDALDOSTERONE • Give an indication of mineralocorticoid activity. • Adrenal insufficiency – Low aldosterone level with high renin
  • 35.
    Management • Hormone replacementHormonereplacement • Life-long replacement therapy • Hydrocortisone and 9α-fludrocortisone • Secondary adrenocortical insufficiency • Hormone replacement • may also require more definitive treatment e.g. surgical removal of a pituitary tumour.
  • 36.
    Management • Adrenal crisis: • Adequate resuscitation e.g. IV fluids, IV glucose. • IV hydrocortisone 100mg which should be continued four times daily afterwards until the patient can take oral medication.
  • 37.
    Disorders of adrenalcortexDisorders of adrenal cortex
  • 38.
    Adrenal Dysfunction Increase function •Cushing syndrome High Cortisol • Hyperaldosteronism High aldestrone • Pheochromocytoma High catecholamine .
  • 39.
    Hyperaldosteronism • A medicalcondition where too much aldosterone is produced by the adrenal glands, which can lead to sodium retention and potassium loss. • Types: – Primary hyperaldosteronism – Secondary hyperaldosteronism
  • 40.
    Primary hyperaldosteronismPrimary hyperaldosteronism (hyporeninemichyperaldosteronism)(hyporeninemic hyperaldosteronism) Conn’s syndromeConn’s syndrome
  • 41.
    Primary aldosteronismPrimary aldosteronism CONN’SSYNDROME • Characterized by autonomous excessive production of aldosterone by adrenal glands • Presents with HPT, hypokalaemic alkalosis and renal K+ wasting
  • 42.
    Conn’s Syndrome • Causes: –Adrenal adenoma – Bilateral hypertrophy of zona glomerulosa cells – Adrenal carcinoma • Rare cause
  • 43.
    Secondary aldosteronism • Isincreased adrenal production ofIs increased adrenal production of aldosterone in response to non-pituitary,aldosterone in response to non-pituitary, extra-adrenal stimuliextra-adrenal stimuli • Increase renin secretion – (hyperreninemic hyperaldosteronism) • Commoner than primary aldosteronism
  • 44.
    Secondary aldosteronism • Common –CCF – Liver cirrhosis with ascites – Nephrotic Syndrome • Less common – Renal artery stenosis – Sodium – losing nephritis – Renin-secreting tumours
  • 45.
    Conn’s syndrome • Clinicalfeatures: – HypertensionHypertension : aldosterone induced Na retention with increase in ECF volume – Muscle weaknessMuscle weakness: Due to decrease K+ – Muscle paralysis:Muscle paralysis: severe hypokalaemia – Latent tetanytetany and paraesthesiaeparaesthesiae – PolydipsiaPolydipsia, polyuriapolyuria and nocturianocturia: due to hypokalaemic nephropathy
  • 46.
    INVESTIGATION • Electrolyte &blood gasses:Electrolyte & blood gasses: – Hypernatraemia – Hypokalaemica – Alkalosis – Urinary potassium loss, level > 30 mmol daily during hypokalaemia
  • 47.
    INVESTIGATION • Plasma aldosterone: renin activity ratioPlasma aldosterone : renin activity ratio – Sensitive screening test – No need to standardize posture Ratio Interpretation Action <800 Diagnosis excluded Seek other cause >1000,<2000 Diagnosis possible Confirmatory test >2000 Diagnosis very likely Establish cause
  • 48.
    Diagnosis • Perform salineinfusion test (sodium loading)Perform saline infusion test (sodium loading) – Method : infusion of 1.25L of 0.9%saline over 2 hrs – Result: plasma aldosterone remains >240 pmol/l confirm Conn’s syndrome
  • 49.
    Establish cause • PlasmaAldosterone level • Method: – Morning blood sample (pt stayed recumbent since waking) – Second sample after 4 hrs stayed ambulant **Standing renal blood flow  stim renin sec  aldosterone level
  • 50.
    • Imaging techniques –CT scan – MRI – Can differentiate adenoma from hyperplasia Establish cause
  • 51.
    Treatment • Tumour – Removesurgically • Bilateral adrenal hyperplasia – Spironolactone
  • 52.
    Disorders of adrenalcortexDisorders of adrenal cortex
  • 53.
    CUSHING’S SYNDROME • Definition •Clinical features • Investigations – Screening for Cushing’s syndrome – Elucidation of the cause of Cushing’s syndrome • Management
  • 54.
    CUSHING’S SYNDROME Adrenal cortexhyperfunction • Any condition resulting from overproduction of primarily glucocorticoid (cortisol) • Mineralocorticoid and androgen may also be excessive
  • 55.
    Pseudo-Cushing’s syndrome • Appearcushingoid and have some biochemical abnormalities of true Cushing’s disease • Causes – Severe depression – Alcoholism – Obesity – Polycystic ovarian syndrome
  • 56.
    Etiology • Excessive cortisol(ACTH dependent)~~75% – Pituitary disease • Adenoma (90%) • Hyperplasia (10 %) – Ectopic ACTH syndrome • Malignancy - ( bronchus, thymus, pancreas, ovary ) – Ectopic CRH syndrome – Exogenous ACTH administration
  • 57.
  • 58.
    ACTH dependent causes *Hypersecretionof ACTH and Cortisol is greater in ectopic ACTH syndrome than Cushing Disease
  • 59.
    Etiology • Excessive cortisol(ACTH independent) ~25%~25% – Adrenal tumour • Adenoma • carcinoma – Nodular hyperplasia – Exogenous glucocorticoid administration
  • 60.
  • 61.
    Etiology • Excess cortisolbinding globulinExcess cortisol binding globulin – Estrogen therapy : Osteoporosis, OCP – Pregnancy
  • 62.
    Clinical features • Truncalobesity with deposition of adipose tissue in characteristic site (moon face, buffalo hump)– exact mechanism unknown • Thinning of skin – catabolic response • Purple striae – catabolic response • Excessive bruising – catabolic response
  • 63.
    Cont.. • Hirsutism (esp adrenal carcinoma ) - ↑ adrenal androgen • Menstrual irregularities - ↑ adrenal androgen • Skin pigmentation ( ACTH ↑ ) – melanocyte stimulating activity
  • 64.
    Cont.. • Hypertension –mineralocorticoid effect → sodium retention – Potassium wasting → hypokalamic alkalosis • Glucose intolerance - ↑ hepatic gluconeogenesis and insulin resistance • Muscle weakness and wasting – catabolic response in peripheral supportive tissue
  • 65.
    Cont.. • Back pain( osteoporosis and vertebral collapse) – inhibit bone formation • Psychiatric disturbances – euphoria, mania, depression
  • 67.
    Laboratory investigations  Thereare two diagnostic steps in the investigation of patient suspected of having Cushing's syndrome  Screening test for identification of Cushing's syndrome. the demonstration of high plasma cortisol level  Identification of cause
  • 68.
    1. Demonstration ofincreased cortisol  Assessment of circadian rhythm in cortisol secretion  24-Hour urinary free cortisol excretion  Overnight / low dose dexamethasone suppression test
  • 69.
    Laboratory investigations 1. Assessmentof circadian rhythm in cortisol secretion.  Measure 8 am and 11 pm serum cortisol level  Normal : Serum value @ midnight is 50% less than value @ 8 am  Cushing’s syndrome : rhythum is loss  Pseudo-Cushing : normal circadian.
  • 70.
    Laboratory investigations 2. Measuring24-hour urinary free cortisol Level (umol/ 24 h )Level (umol/ 24 h ) InterpretationInterpretation < 300< 300 NormalNormal 300 - 700300 - 700 Severe depressionSevere depression StressStress > 700> 700 Diagnostic ofDiagnostic of Cushing's syndromeCushing's syndrome
  • 71.
    Laboratory investigations 3. Lowdose Dexamethasone suppression test :  0.5 mg Dexametason (oral) given 6 hourly for 2 days  blood for plasma cortisol collected 6 hour after last dose  urine for UFC is collected before & on the 2nd day of Dexa  Result:  UFC suppress by 50% ( < 70nmol/24h) normal  plasma cortisol suppress < 140 nmol/L pseudo- Cushing  no suppression of UFC & Pl. cortisol Cushing's synd
  • 72.
    Elucidation of thecause • High dose Dexamethasone suppression test • Normal individuals suppress plasma cortisol to < 50 nmol/L. • Patients with Cushing's syndrome fail to show complete suppression of plasma cortisol levels. This test is highly sensitive (> 97%).
  • 73.
    2. Elucidation ofthe cause • Plasma ACTH – Normal < 50 ng/L – Low – adrenal causes – Elevated • Slight – pituitary dependent Cushing’s • Gross – ectopic secretion of ACTH
  • 74.
    Elucidation of thecause • CRH Test – Differentiate ectopic ACTH secretion and Cushing’s disease. – Cushing’s disease – plasma ACTH increases 50% over baseline and cortisol increase by 20% – Ectopic ACTH or adrenal tumour – no response
  • 75.
    Elucidation of thecause • Imaging – CT scan of adrenal gland: TRO adrenal tumor – MRI of pituitary gland: majority microadenoma ( < 10mm). MRI reveal lesion in 50 - 60% of cases – CT scan/MRI of thorax & abdomen: ectopic ACTH producing tumor
  • 76.
    Treatment • Depend ofCushing's syndrome depends on the etiology: – Adrenal adenoma – Adrenal Carcinoma – resection – Cushing’s disease - transphenoidal hyposectomy – Drug ( block cortisol synthesis ) - metyrapone